Literature DB >> 22488095

The role of radiation therapy in the management of adrenal carcinoma and adrenal metastases.

Sarah A Milgrom1, Karyn A Goodman.   

Abstract

The use of radiation therapy (RT) to treat adrenal tumors has historically been limited by the risk of normal tissue toxicity, given the proximity of the adrenals to radiosensitive structures, such as the kidney, stomach, intestine, and spinal cord. However, contemporary techniques have made RT safe and effective for use in the management of adrenal carcinoma and adrenal metastases. Data on recent advances in the use of RT to treat adrenocortical carcinoma and adrenal metastases are reviewed, in both surgical and non-surgical settings.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22488095     DOI: 10.1002/jso.23096

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  10 in total

Review 1.  Multi-organ resection for locally advanced adrenocortical cancer: surgical strategy and literature review.

Authors:  F Guida; M Clemente; L Valvano; C Napolitano
Journal:  G Chir       Date:  2015 Sep-Oct

Review 2.  Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer.

Authors:  Neil B Desai; Aaron M Laine; Robert D Timmerman
Journal:  Br J Radiol       Date:  2016-12-23       Impact factor: 3.039

3.  Adrenocortical carcinoma: modern management and evolving treatment strategies.

Authors:  Lucas A McDuffie; Rachel D Aufforth
Journal:  Int J Endocr Oncol       Date:  2016-04-08

4.  Oligometastatic non-small cell lung cancer (NSCLC): adrenal metastases. Experience in a single institution.

Authors:  Mirko Barone; Decio Di Nuzzo; Giuseppe Cipollone; Pierpaolo Camplese; Felice Mucilli
Journal:  Updates Surg       Date:  2015-11-20

5.  The efficacy of radiation therapy in adrenocortical carcinoma: A propensity score analysis of a population-based study.

Authors:  You Luo; San-San Chen; Xiang-Guang Zheng; Li Luo; Sen Wang
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

Review 6.  Health-Related Quality of Life in Adrenocortical Carcinoma.

Authors:  Rebecca V Steenaard; Laura A Michon; Harm R Haak
Journal:  Cancers (Basel)       Date:  2019-10-08       Impact factor: 6.639

Review 7.  Successful treatment of metastatic adrenocortical carcinoma in the spine: A case report and literature review.

Authors:  Shuzhong Liu; Xi Zhou; An Song; Zhen Huo; Yipeng Wang; Yong Liu
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

8.  Current management options for recurrent adrenocortical carcinoma.

Authors:  Anthony R Glover; Julian C Y Ip; Jing Ting Zhao; Patsy S H Soon; Bruce G Robinson; Stan B Sidhu
Journal:  Onco Targets Ther       Date:  2013-06-06       Impact factor: 4.147

9.  Adrenocortical Carcinoma: Current Therapeutic State-of-the-Art.

Authors:  Amir H Lebastchi; John W Kunstman; Tobias Carling
Journal:  J Oncol       Date:  2012-10-18       Impact factor: 4.375

10.  Antineoplastic Effect of a Combined Mitotane Treatment/Ionizing Radiation in Adrenocortical Carcinoma: A Preclinical Study.

Authors:  Lidia Cerquetti; Barbara Bucci; Giulia Carpinelli; Pina Lardo; Antonella Proietti; Raffaele Saporito; Guido Rindi; Elisa Petrangeli; Vincenzo Toscano; Antonio Stigliano
Journal:  Cancers (Basel)       Date:  2019-11-09       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.